I

Inimmune

28 employees

Inimmune is focused on the discovery and development of novel immunotherapeutics for an array of disease areas.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Chemical synthesis
Innate immunity
Health Care
Immunotherapeutics

Date founded

2016

Funding rounds raised

Total raised

$22M

from 2 investors over 2 rounds

I

Inimmune raised $22M on July 9, 2020

Investors: Two Bear Capital

I

Inimmune raised $593K on October 5, 2018

Investors: National Institute of Allergy and Infectious Diseases (NIAID)

FAQ